3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
20
Carcinoma, Renal Cell
10
Neuroendocrine Tumors
7
Neoplasm Metastasis
7
Recurrence
4
Tuberous Sclerosis
3
Triple Negative Breast Neoplasms
3
Neoplasms
3
Kidney Neoplasms
3
Endometrial Neoplasms
3
von Hippel-Lindau Disease
2
Skin Neoplasms
2
Sarcoma
2
Meningioma
2
Glioma
2
Gastro-enteropancreatic neuroendocrine tumor
2
Diffuse Intrinsic Pontine Glioma
2
Carcinoma, Hepatocellular
2
Adenoma, Islet Cell
2
Waldenstrom Macroglobulinemia
1
Vascular Malformations
1
Unilateral Breast Neoplasms
1
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Thymus Neoplasms
1
Seizures
1
Sarcoma, Kaposi
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Interventions
Megestrol Acetate
4
Progestins
3
Tirzepatide
2
Letrozole
2
Biopsy
2
semaglutide
1
exemestane
1
Tamoxifen
1
Surveys and Questionnaires
1
Sampling Studies
1
Restraint, Physical
1
Resistance Training
1
Pterocarpus marsupium
1
Pharmacogenomic Variants
1
Observation
1
Nutrition Assessment
1
Metformin
1
Medroxyprogesterone Acetate
1
Magnetic Resonance Spectroscopy
1
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
1
Intrauterine Devices
1
Hysteroscopy
1
Hysterectomy
1
Everolimus
1
Estrogen Replacement Therapy
1
Cyproterone acetate, ethinyl estradiol drug combination
1
Curettage
1
Blood Specimen Collection
1
3,5-dimethoxy-4'-hydroxystilbene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endometrial Hyperplasia
×
Everolimus
×
1 year
×
Clear all
NCT02397083
2026-02-13
LEVER
M.D. Anderson Cancer Center
Phase 2
Active not recruiting
102 enrolled